| | | Invest in the | | Supriya Lifescience Ltd. IPO | | | through Kotak Bank’s ASBA facility | | Issue period: Dec 16 – Dec 20, 2021 | | | | | | | | | Dear Anita Kubhar, | | The ASBA (Application Supported by Blocked Amount) facility allows you to block application money in your Kotak Savings Account for investing in any IPO/FPO/Bonds/Rights issue. | | With ASBA, the money in your account does not get debited until the shares you have applied for are allotted to you. Also, you can earn interest on the blocked amount till the allotment of shares! | | Supriya Lifescience Ltd. IPO details | | | Issue Period | Thursday, December 16, 2021 to Monday, December 20, 2021 | | Price Band | ₹265/- to ₹274/- per equity share | | Issue Size | ₹700/- Crs @ upper band price | | Bid Lot | 54 equity shares & in multiples of 54 equity shares thereafter | | | | Please refer to the Red Herring Prospectus of Supriya Lifescience Ltd. IPO for risk factors and further details | | How to apply for IPO: |  | | Log in to Kotak Mobile Banking App | | | | |  | | Look for IPO (ASBA) in the investment tab | | | | | | | |  | | IPO ends in |  | | Invest easily via: | | | | | |  | Phone Banking
1860 266 2666
(local call charges apply) | | | | | | | Why choose Kotak Bank's ASBA facility: |  |  | | No cheque/demand draft required to pay for the application money | | | | |  | | | You get to apply through any Demat Account | | | | |  | | | Option to revise or withdraw the application (only for Retail Investors) till the closure of the issue. Facility only available on Net/Branch Banking | | | | | | | Warm regards,
Team Kotak Mahindra Bank | Terms and conditions apply.
On 20 December, 2021 Supriya Lifescience Ltd. IPO application should be executed before 2:00 pm on Kotak Mobile Banking, Net Banking and Customer Contact Centre.
The aforesaid is for information purposes only and should not be construed to be investment advice under SEBI (Investment Advisers) Regulations. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. | | | | | | | | Please do not reply to this mail as this is an automated mail service. | | |
No comments: